Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a significant drop in short interest in October. As of October 31st, there was short interest totalling 53,800 shares, a drop of 17.2% from the October 15th total of 65,000 shares. Based on an average daily trading volume, of 22,000 shares, the short-interest ratio is currently 2.4 days.

Apollomics Stock Performance

APLMW opened at $0.01 on Friday. Apollomics has a 1-year low of $0.01 and a 1-year high of $0.06. The firm has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.